(Q38199524)

30 August 2017

title

Interleukin-8 and interleukin-17 for cancer (English)

1 reference

30 August 2017

0 references

Paul Zarogoulidis

1

1 reference

30 August 2017

Fotini Katsikogianni

2

1 reference

30 August 2017

Theodora Tsiouda

3

1 reference

30 August 2017

Antonios Sakkas

4

1 reference

30 August 2017

Nikolaos Katsikogiannis

5

1 reference

30 August 2017

Konstantinos Zarogoulidis

6

1 reference

30 August 2017

publication date

26 March 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

32

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

197-205

1 reference

Interleukin-8 and human cancer biology

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Dysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Interleukin-17 family and IL-17 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

IL-17 promoted metastasis of non-small-cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for gliblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Role of interleukin‐17 in lymphangiogenesis in non‐small‐cell lung cancer: Enhanced production of vascular endothelial growth factor C in non‐small‐cell lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Elevated levels of anti inflammatory IL-10 and pro inflammatory IL-17 in malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Luteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Role of IL-8 induced angiogenesis in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Cytokine patterns in brain tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

CT perfusion can predict overexpression of CXCL8 (interleukin-8) in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

E6 and E7 of human papillomavirus type 18 and UVB irradiation corporately regulate interleukin-6 and interleukin-8 expressions in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

A soft coral natural product, 11-episinulariolide acetate, inhibits gene expression of cyclooxygenase-2 and interleukin-8 through attenuation of calcium signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Polymorphism in the interleukin-17A promoter contributes to gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Chemoresistance of human monocyte-derived dendritic cells is regulated by IL-17A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

BATF regulates the development and function of IL-17 producing iNKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.898156

10.3109/07357907.2014.898156

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference